Compare Stanley Black & Decker, Inc. (SWK) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stanley Black & Decker, Inc. vs Tenet Healthcare Corporation — how do they compare? Stanley Black & Decker, Inc. trades at $89.66 (market cap $13.34B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Stanley Black & Decker, Inc. pays a 3.8% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stanley Black & Decker, Inc. for 62 Days and Tenet Healthcare Corporation for 15 Days on average.
| SWK | THC | |
|---|---|---|
Market Cap | $13.34B | $20.92B |
Volume | 1,609,355 | 455,764 |
Sector | Industrials | Health |
52-Week High | $104.00 | $280.77 |
52-Week Low | $62.12 | $161.37 |
Typical Hold Time | 62 Days | 15 Days |
Enterprise Value | $17.50B | $32.00B |
Dividend Yield | 3.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stanley Black & Decker (SWK) trades at $89.17, down 0.91% on the day, with a bearish technical signal from moving averages and oscillators. The company has beaten earnings estimates in recent quarters, with Q3 2026 results expected on November 4, 2026. Financials show improving net income margins, from 1.91% in 2024 to 2.65% in 2025, supported by strong cash flow from operations of $971.20 million in 2025. Recent news highlights product launches like the dustbuster® mini™ and management's focus on margin gains.
SWK presents a mixed outlook with a consensus price target of $93.00 implying modest upside. Strengths include a solid dividend history and earnings beats, but risks involve persistent bearish technical indicators and competitive pressures. The stock's valuation metrics, such as a P/E of 21.59 and P/S of 0.88, suggest reasonable pricing relative to peers, though investor sentiment remains cautious amid macroeconomic uncertainties.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
